KangStem Biotech said that it has signed a deal with Seoul National University’s R&DB Foundation to receive the university’s skin organoid manufacturing technology.The technology uses a three-dimensional (3D) air-liquid interface (ALI) skin organoid preparation from human pluripotent stem cells for